This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 14 - 17, 2025
Marriott Marquis San DiegoLive In-Person Event: December 14 - 17, 2025
BOOK NOW
Menu
BOOK NOW

Yuri Teranishi-Ikawa
Principal Scientist at Chugai Pharmabody Research Pte. Ltd.
Speaker

Profile

Ms. Yuri Teranishi-Ikawa joined Chugai Pharmaceutical Co., Ltd. as a research scientist in 2012. She has been engaged in lead antibody acquisition using phage display technology and multidimensional optimization of lead antibodies for over 10 years. During her career, she was assigned to Chugai Pharmabody Research in Singapore, where she further developed her expertise in antibody optimization. She has experience as a project leader on multiple projects and has also initiated new projects, including the development of novel antibody engineering technologies.

Agenda Sessions

  • DONQ52: A Broadly Cross-Reactive Neutralizing Antibody against Multiple Gluten peptide/HLA-DQ2.5 Complexes for Treatment of Celiac Disease

    , 10:30am
    View Session

At this event

Prev
Next
Peter Tessier, PhD
Albert M. Mattocks Professor, Departments of Pharmaceutical Sciences, Chemical Engineering and Biomedical Engineering
University of Michigan

See Yuri at Antibody Engineering & Therapeutics US

BOOK NOW